𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C

✍ Scribed by G. Sroczynski; E. Esteban; A. Conrads-Frank; R. Schwarzer; N. Mühlberger; D. Wright; S. Zeuzem; U. Siebert

Book ID
108886298
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
130 KB
Volume
17
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of hepatitis C virus
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
✍ Natasha K. Martin; Peter Vickerman; Alec Miners; Graham R. Foster; Sharon J. Hut 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed countries. HCV antiviral treatment (peginterferon-a 1 ribavirin) has been shown to be costeffective for patients with no reinfection risk. We examined the cost-effectiveness of providing antiviral treatment

Cost-effectiveness of interferon alfa 2b
Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th